NEUROFIBROMATOSIS 2
Clinical trials for NEUROFIBROMATOSIS 2 explained in plain language.
Never miss a new study
Get alerted when new NEUROFIBROMATOSIS 2 trials appear
Sign up with your email to follow new studies for NEUROFIBROMATOSIS 2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Drug trial aims to slow tumor growth in rare genetic disorder
Disease control CompletedThis study tested whether the oral drug crizotinib could slow or reduce the growth of vestibular schwannoma tumors in people with Neurofibromatosis Type 2 (NF2). Twelve participants with NF2 and confirmed tumor progression took crizotinib daily in 28-day cycles, for up to one yea…
Matched conditions: NEUROFIBROMATOSIS 2
Phase: PHASE2 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Virtual training helps NF patients cope with stress and symptoms
Symptom relief CompletedThis study tested two different online stress and symptom management programs for adults with neurofibromatosis (NF1, NF2, or Schwannomatosis). Researchers compared how these live video programs affected participants' quality of life, stress levels, and ability to cope with their…
Matched conditions: NEUROFIBROMATOSIS 2
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Apr 01, 2026 14:41 UTC